Cargando…
Clinical Evaluation of BRCA1/2 Mutation in Mexican Ovarian Cancer Patients
Ovarian cancer (OC) is an important cause of gynecologic cancer-related deaths. In Mexico, around 4700 new cases of OC are diagnosed per year and it represents the second cause of gynecological cancer mortality with more than 2700 deaths. Germline mutations in BRCA1/2 genes are present in 13–18% of...
Autores principales: | Gallardo-Rincón, Dolores, Álvarez-Gómez, Rosa María, Montes-Servín, Edgar, Toledo-Leyva, Alfredo, Montes-Servín, Elizabeth, Michel-Tello, David, Alamilla-García, Gabriela, Bahena-González, Antonio, Hernández-Nava, Elizabeth, Fragoso-Ontiveros, Veronica, Espinosa-Romero, Raquel, Cetina-Pérez, Lucely |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6931216/ https://www.ncbi.nlm.nih.gov/pubmed/31869745 http://dx.doi.org/10.1016/j.tranon.2019.11.003 |
Ejemplares similares
-
Clinical Benefits of Olaparib in Mexican Ovarian Cancer Patients With Founder Mutation BRCA1-Del ex9-12
por: Gallardo-Rincón, Dolores, et al.
Publicado: (2022) -
Impact of metabolic syndrome on the risk of endometrial cancer and the role of lifestyle in prevention
por: Pérez-Martín, Alejandra Rocío, et al.
Publicado: (2022) -
Mexican BRCA1 founder mutation: Shortening the gap in genetic assessment for hereditary breast and ovarian cancer patients
por: Fragoso-Ontiveros, Veronica, et al.
Publicado: (2019) -
CD47 overexpression is associated with decreased neutrophil apoptosis/phagocytosis and poor prognosis in non-small-cell lung cancer patients
por: Barrera, Lourdes, et al.
Publicado: (2017) -
Full-Exon Pyrosequencing Screening of BRCA Germline Mutations in Mexican Women with Inherited Breast and Ovarian Cancer
por: Vaca-Paniagua, Felipe, et al.
Publicado: (2012)